There is already a large amount of evidence to support green tea’s role in protecting against different cancers.
A study published in the Journal of Clinical Oncology now suggests that a concentrated extract of epigallocatechin gallate (EGCG), found in green tea, may assist in the treatment of chronic lymphocytic leukaemia (CLL), which is the most common kind.
Researchers at the prestigious Mayo Clinic gave patients with CLL between 400mg and 2000mg of EGCG daily. After just one month, lymphocyte count was reduced by around 20 percent in one-third of the patients.
Your say: Do you drink green tea? Share your thought below…
Related stories
Native ad body.
Sponsored by %%sponsor_name%%
Native ad body.
Sponsored by %%sponsor_name%%
Native ad body.
Sponsored by %%sponsor_name%%
Native ad body.
Sponsored by %%sponsor_name%%
